Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks ...

Group 1: Halozyme Therapeutics - Halozyme Therapeutics is a biopharmaceutical company focused on developing and commercializing novel treatments for oncology by targeting the tumor microenvironment [1] - The company has a Zacks Rank of 1 (Strong Buy) and its current year earnings estimate has increased by 10.5% over the last 60 days [1] - Halozyme's shares have gained 36.2% over the last three months, significantly outperforming the S&P 500's gain of 7.5%, and it possesses a Momentum Score of A [2] Group 2: T. Rowe Price - T. Rowe Price is a global investment management organization offering a wide range of mutual funds, sub-advisory services, and separate account management for various investors [3] - The company also holds a Zacks Rank of 1 and has seen a 9% increase in its current year earnings estimate over the last 60 days [3] - T. Rowe Price's shares have increased by 14.2% over the last three months, again outperforming the S&P 500's gain of 7.5%, and it has a Momentum Score of A [4] Group 3: Cars.com - Cars.com operates an online automotive platform that provides listings for new and used vehicles, along with expert and consumer reviews and research tools [4] - The company has a Zacks Rank of 1 and its current year earnings estimate has risen by 2.3% over the last 60 days [4] - Cars.com's shares have appreciated by 22.3% over the last three months, surpassing the S&P 500's gain of 7.5%, and it also has a Momentum Score of A [5]